Thompson Davis & Co., Inc. Novo Cure LTD Transaction History

Thompson Davis & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $28,155 - $45,746	-375 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$19.3 - $23.65 $2,412 - $2,956	125 Added 50.0%	375 $8,000
Q4 2017 Feb 05, 2018	BUY	$16.3 - $21.9 $4,075 - $5,475	250 New	250 $5,000
Q3 2017 Oct 30, 2017	SELL	$18.05 - $21.75 $4,512 - $5,437	-250 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	250	250 $4,000

265

77.1M

751K

293K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.59B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.